Murine models for Down syndrome

Physiology and Behavior

Volumn 73, Issue 5, 2001, Pages 859-871

  Dierssen, Mara ^a   Fillat, Cristina ^a   Crnic, Linda ^b   Arbonés, Mariona ^a   Flórez, Jesús ^c   Estivill, Xavier ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

BAC; Central nervous system; Down syndrome; Hypotonia; Learning; Memory; Mental retardation; Mouse; Transgenic; Trisomic; YAC

Indexed keywords

DNA; GENE PRODUCT; PROTEOME;

ANIMAL MODEL; AUTOSOMAL DISORDER; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 21; CLINICAL FEATURE; DOWN SYNDROME; FETUS; GENE OVEREXPRESSION; GENOME; KNOCKOUT MOUSE; NONHUMAN; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TRANSGENIC ANIMAL; TRISOMY; YEAST ARTIFICIAL CHROMOSOME;

EID: 0034837339     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(01)00523-6     Document Type: Article

References (100)

1. Transgenic model of memory deficit in Down syndrome: Role of the minibrain kinase
2. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse
3. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity
4. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
5. Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors
6. Genesis and systematization of cardiovascular anomalies in murine trisomy 16
7. Characterization of transgenic mice with an increased content of chromosomal protein HMG-14 in their chromatin. DNA
8. YAC transgenic mice in the study of the genetic basis of Down syndrome
9. Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency
10. A YAC contig map of the human genome
11. Motor dysfunction in a mouse model for Down syndrome
12. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field
13. Down syndrome and the trisomy 16 mouse: Impact of gene imbalance on brain development and aging
14. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
15. Down syndrome: Neuropsychology and animal models
16. Segmental trisomy for murine chromosome 16: A new system for studying Down syndrome
17. Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome
18. Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model
19. Insertion of a pathogenic mutation into a yeast artificial chromosome containing the human amyloid precursor protein gene
20. Overexpression of liver-type phosphofructokinase (PKLF) in transgenic-PKLF mice: Implications for gene dosage in trisomy 21
21. Mild impairment of learning and memory in mice overexpressing the mSim2 gene located on chromosome 16: An animal model of Down's syndrome
22. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome
23. The metabolic and molecular basis of inherited disease
24. Behavioral assessment of Ts65Dn mice: A putative DS model
25. Impaired short and long-term memory in Ts65Dn mice, a model for DS
26. Neurologic abnormalities
27. Alzheimer-type neuropathology in transgenic mice overexpressing V717F b-amyloid precursor protein
28. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice
29. Autosomal aneuploidy in mice: Generation and developmental consequences
30. Gene targeting studies of mammalian behavior: Is it the mutation or the background phenotype?
31. Female specific hyperactivity in S100 beta transgenic mice does not habituate in the open-field
32. Spatial and nonspatial learning in mice: Effects of S100 beta overexpression and age
33. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration
34. Intraneuronal Abeta42 accumulation in human brain
35. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome
36. Morphogenesis of the brain and craniofacial complex in trisomy 16 mice
37. Transgenic models for HSA21 gene dosage
38. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region
39. Mutant CuZn superoxide dismutase in motor neuron disease
40. The DNA sequence of human chromosome 21. The chromosome 21 mapping and sequencing consortium
41. Consequences of trisomy 16 for mouse brain development: Corticogenesis in a model of Down syndrome
42. Role of founder cell deficit and delayed neurogenesis in microcephaly of the trisomy 16 mouse
43. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21
44. Analysis of mammalian central nervous system gene expression and function using bacterial artificial chromosome-mediated transgenesis
45. Engineering chromosomes in mice through targeted meiotic recombination (TAMERE)
46. Specificity determinants of substrate recognition by the protein kinase DYRK1A
47. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
48. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
49. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
50. Hippocampal volume and neuronal number in Ts65Dn mice: A murine model of Down syndrome
51. Specific impairment of cardiogenesis in mouse ES cells containing a human chromosome 21
52. Minibrain/DYRK1A gene: Candidate gene for mental retardation in Down's syndrome?
53. Animal models in the study of the biological function of genes on HSA21 and their role in the pathophysiology of Down syndrome
54. Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps
55. Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice
56. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice
57. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice
58. Spontaneous stereotypy in an animal model of Down syndrome (Ts65Dn mice)
59. Brain adenylyl cyclase and phospholipase C signaling pathways in Alzheimer's disease and Down syndrome
60. Reduced responsiveness of Ts65Dn mice to pain
61. Enriched environment and behavioral performance of Ts65Dn mice, a model for Down syndrome: Gender differences
62. Comparative study of phenotypic expression of mice trisomy 16 by different female strains: Attempt at an animal model for human trisomy 21
63. Aggressive behavior in transgenic mice expressing APP is alleviated by serotonergic drugs
64. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain
65. Valoración ecográfica mediante doppler pulsado de la función cardíaca en el ratón Ts65Dn un modelo murino de síndrome de Down
66. Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor cognitive or neurodegenerative sequelae following experimental brain injury
67. Application of antisense DNA method for the study of molecular bases of brain function and behavior
68. High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development
69. The neurobiologic consequences of autosomal aneuploidy in mice and men
70. Neurotransmitter alterations in the trisomy 16 mouse: A genetic model system for studies of Down syndrome
71. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome
72. Altered brain glucose metabolism in transgenic-PFKL mice with elevated l-phosphofructokinase: In vivo NMR studies
73. Medial prefrontal cortical injections of c-fos antisense oligonucleotides transiently lower c-Fos protein and mimic amphetamine withdrawal behaviors
74. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome
75. Phenotypic characteristics
76. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice
77. A mouse model for Down syndrome exhibits learning and behaviour deficits
78. Parallels of craniofacial development in Down syndrome and Ts65Dn mice
79. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
80. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
81. q/11 subunits in the mouse Ts65Dn brain and potential implications
82. TslCje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities
83. Genetic dissection of the region associated with behavioral abnormalities in mouse models for Down syndrome
84. Effects of over- and under-expression of Cu, Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum
85. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease
86. The Down syndrome critical region
87. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome
88. Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from HSA21q22.2
89. Functional screening of 2 Mb of HSA21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome
90. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice
91. A new aspartyl protease on 21q22.3 BACE2, highly similar to Alzheimer's amyloid precursor protein β-secretase
92. The amyloid precursor protein of Alzheimer's disease and the Ab peptide
93. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
94. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice
95. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice
96. Oxidative stress mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease
97. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome
98. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
99. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome
100. Effects of NMDA-R1 antisense oligodeoxynucleotide administration: Behavioral and radioligand binding studies